Eloise was diagnosed with Stage III rhabdomyosarcoma in March 2008, several months after her 12th birthday. She bravely underwent chemo and radiation from March 2008 – February 2009. At the end of her treatment, she was deemed NED – ‘no evidence of disease.’
Unfortunately as she was preparing to return to school in late August 2009, she was diagnosed with recurrent rhabdomyosarcoma. The prognosis was grim. Once again, her bravery and hope shone through and she asked that we not ‘take her hope away.’ Those next nine months were a gift but she passed away on May 1st, 2010.
Eloise’s family has become a very dedicated and devoted one during the past 5 years. They believe wholeheartedly in CureSearch’s mission: Research is the key to the cure.
Establishing a Legacy Fund in Eloise’s name at her 5 year anniversary is very important to her parents and surviving sister as well as both of their extended families and friends. Her family is extremely appreciative of the moral and financial support that has resulted in their efforts at nearly a dozen Walks held throughout the country during the last five years.
Eloise’s mother Annie now serves on CureSearch’s Board as of 2014. As Annie has said: “there was no master plan” after Eloise’s death but this has given them the ability to give back and remain hopeful that one day, there will be a cure for all childhood cancers.
Donations made to the Fund will be dedicated to CureSearch’s Acceleration Initiative, our research agenda aimed at achieving breakthroughs in treatments and cures. These International Grand Challenge Awards seek to address two critical challenges facing pediatric cancer treatment and are open to submissions by top researchers from around the world. The two areas of focus are: creating novel approaches to childhood cancer survivorship and accelerating the delivery of new therapeutic agents for pediatric patients.